论文部分内容阅读
最近,美国学者进行的一项研究表明,局部治疗方法(LRT)的影像学反应性可预测肝细胞癌(HCC)患者的生存时间。反应的欧洲肝脏研究协会(EASL)标准,较世界卫生组织(WHO)标准,在预测生存时间方面具有更好的一致性。LRT的治疗目标应该是实现放射反应,而不仅仅是稳定疾病。HCC患者的生存时间是否与他们对治疗的反应相关目前并不清楚。研究者们分析了肿瘤反应与LRT(化疗栓塞和放射栓塞)治疗的HCC患者的生存时间之间的相关性。
Recently, a study by American researchers showed that the imaging reactivity of topical treatment (LRT) predicts survival in patients with hepatocellular carcinoma (HCC). The response to the European Association for the Study of the Liver (EASL) criteria is more consistent with the World Health Organization (WHO) criteria in predicting survival. The goal of LRT should be to achieve a radiological response, not just to stabilize the disease. Whether HCC patients’ survival time is related to their response to treatment is not clear at this time. The researchers analyzed the correlation between tumor response and survival in HCC patients treated with LRT (chemoembolization and radiation embolism).